Suncoast Equity Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Suncoast Equity Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-41,487	Closed	-$25.1M	–	58
2021 Q3	$25.1M	Sell	41,487 -2,513	-6%	-$1.56M	3.51%	15
2021 Q2	$24.6M	Sell	44,000 -440	-1%	-$223K	3.21%	16
2021 Q1	$21M	Buy	44,440 +13,642	+44%	+$6.64M	3.1%	16
2020 Q4	$14.9M	Buy	+30,798	New	+$16.6M	2.32%	18

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Suncoast Equity Management's REGN Position: Q4 2021 in Review

Suncoast Equity Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2021, closing a stake of 41,487 shares — an estimated $25.1M sold.

Suncoast Equity Management first reported a position in REGN in Q4 2020 and held it in 4 quarters. The position peaked at $25.1M in Q3 2021. 1,080 funds tracked by Wall St. Rank hold REGN as of Q4 2021.

Suncoast Equity Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Suncoast Equity Management sold 41,487 Regeneron Pharmaceuticals shares in Q4 2021, an estimated $25.1M.
Suncoast Equity Management first reported a position in Regeneron Pharmaceuticals in Q4 2020 and held it in 4 quarters.
Suncoast Equity Management's Regeneron Pharmaceuticals position peaked at $25.1M in Q3 2021.
1,080 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2021.

Based on Suncoast Equity Management's 13F filing for Q4 2021, filed 28 Jan 2022.